ProKidney (PROK) Institutional Ownership $2.30 -0.06 (-2.54%) Closing price 04:00 PM EasternExtended Trading$2.29 -0.01 (-0.43%) As of 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ProKidney (NASDAQ:PROK)CurrentInstitutional OwnershipPercentage51.59%Number ofInstitutional Buyers(last 12 months)30TotalInstitutional Inflows(last 12 months)$14.41MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$962.45K Get PROK Insider Trade Alerts Want to know when executives and insiders are buying or selling ProKidney stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data PROK Institutional Buying and Selling by Quarter ProKidney Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bank of America Corp DE846,154$501K0.0%+12.4%0.289% 8/14/2025 Jane Street Group LLC591,688$350K0.0%N/A0.202% 8/13/2025 Marshall Wace LLP464,812$274K0.0%N/A0.159% 8/12/2025 JPMorgan Chase & Co.1,668,642$988K0.0%+3,024.9%0.570% 8/12/2025 Catalyst Funds Management Pty Ltd61,100$36K0.0%N/A0.021% 8/8/2025 Geode Capital Management LLC1,012,120$600K0.0%-56.4%0.346% 8/1/2025 Y Intercept Hong Kong Ltd351,622$208K0.0%N/A0.120% 6/27/2025 Goldman Sachs Group Inc.217,969$191K0.0%-25.4%0.074% 5/16/2025 Goldman Sachs Group Inc.217,969$191K0.0%-25.4%0.074% 5/16/2025 AQR Capital Management LLC52,570$46K0.0%+106.4%0.018% Get the Latest News and Ratings for PROK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProKidney and its competitors with MarketBeat's FREE daily newsletter. 5/12/2025 Nuveen LLC266,366$233K0.0%N/A0.091% 5/9/2025 Deutsche Bank AG86,337$76K0.0%+49.4%0.029% 5/9/2025 Charles Schwab Investment Management Inc.825,647$723K0.0%+8.7%0.282% 4/29/2025 Bank of New York Mellon Corp239,673$210K0.0%+4.3%0.082% 4/10/2025 Hennion & Walsh Asset Management Inc.844,277$740K0.0%+48.5%0.288% 2/17/2025 ProShare Advisors LLC30,879$52K0.0%+57.3%0.011% 2/17/2025Nuveen Asset Management LLC266,366$450K0.0%+17.3%0.091% 2/17/2025 Bleichroeder LP2,000,000$3.38M0.9%+8.4%0.686% 2/17/2025 Bank of America Corp DE539,232$911K0.0%+3.2%0.185% 2/17/2025 BNP Paribas Financial Markets65,336$110K0.0%N/A0.022% 2/14/2025 Northern Trust Corp890,907$1.51M0.0%+7.4%0.305% 2/14/2025 Susquehanna Fundamental Investments LLC52,128$88K0.0%N/A0.018% 2/13/2025 Mariner LLC38,119$64K0.0%-29.5%0.013% 2/13/2025 Barclays PLC171,797$290K0.0%+17.4%0.059% 2/13/2025 Renaissance Technologies LLC105,200$178K0.0%+127.7%0.036% 2/13/2025 Wells Fargo & Company MN54,098$91K0.0%+51.7%0.019% 2/12/2025 Geode Capital Management LLC2,231,930$3.77M0.0%+1.3%0.765% 2/12/2025 JPMorgan Chase & Co.66,415$112K0.0%+41.8%0.023% 2/11/2025 Sei Investments Co.41,062$69K0.0%N/A0.014% 2/6/2025 Charles Schwab Investment Management Inc.759,787$1.28M0.0%+1.3%0.261% 2/4/2025 Bank of New York Mellon Corp229,770$388K0.0%+20.6%0.079% 1/30/2025 Rhumbline Advisers80,501$136K0.0%-10.9%0.028% 1/15/2025 Hennion & Walsh Asset Management Inc.568,647$961K0.0%N/A0.195% 12/26/2024 JPMorgan Chase & Co.46,830$90K0.0%+65.1%0.016% 11/19/2024 Barclays PLC146,321$281K0.0%+575.7%0.050% 11/16/2024 Geode Capital Management LLC2,203,934$4.23M0.0%+102.0%0.761% 11/15/2024 Barclays PLC146,321$281K0.0%+575.7%0.051% 11/15/2024 XTX Topco Ltd21,267$41K0.0%N/A0.007% 11/15/2024 Jane Street Group LLC40,530$78K0.0%-14.6%0.014% 11/15/2024 State Street Corp1,428,318$2.74M0.0%+16.2%0.493% 11/14/2024 Suvretta Capital Management LLC12,341,266$23.70M0.8%+32.1%4.260% 11/14/2024 MetLife Investment Management LLC62,660$120K0.0%+90.6%0.022% 11/13/2024 The Manufacturers Life Insurance Company37,981$73K0.0%+54.6%0.013% 11/12/2024 Charles Schwab Investment Management Inc.749,718$1.44M0.0%+150.6%0.259% 11/9/2024 Intech Investment Management LLC24,075$46K0.0%N/A0.008% 10/21/2024 Castleview Partners LLC32,921$63K0.0%N/A0.014% 8/15/2024 Susquehanna Fundamental Investments LLC42,990$106K0.0%N/A0.019% 8/15/2024 The Manufacturers Life Insurance Company24,566$60K0.0%N/A0.011% 8/15/2024 AQR Capital Management LLC20,518$50K0.0%N/A0.009% 8/14/2024 Marshall Wace LLP50,242$124K0.0%N/A0.022% 8/8/2024 Federated Hermes Inc.23,303$57K0.0%-79.4%0.010% 8/1/2024 Rhumbline Advisers76,190$187K0.0%+8.8%0.033% 7/26/2024 Bank of New York Mellon Corp179,236$441K0.0%+44.6%0.078% 5/10/2024 Vanguard Group Inc.1,813,079$2.97M0.0%-37.5%0.791% 4/24/2024 Zullo Investment Group Inc.19,420$32K0.0%N/A0.008% 2/7/2024 Jump Financial LLC21,677$39K0.0%-54.0%0.009% 1/31/2024 Federated Hermes Inc.113,286$202K0.0%+10,984.7%0.048% 1/12/2024 SG Americas Securities LLC46,829$83K0.0%+174.2%0.020% 11/7/2023 New York State Common Retirement Fund17,274$79K0.0%-30.1%0.007% 11/7/2023 Jump Financial LLC47,100$216K0.0%N/A0.020% 10/27/2023 Social Capital Group LLC11,573,000$53.00M89.0%-12.8%4.922% 10/24/2023 Bank of New York Mellon Corp127,956$586K0.0%-21.9%0.054% 10/13/2023 SG Americas Securities LLC17,080$78K0.0%N/A0.007% 8/10/2023 Letko Brosseau & Associates Inc.15,900$178K0.0%N/A0.007% 8/10/2023 Metropolitan Life Insurance Co NY3,429$38K0.0%N/A0.001% 8/4/2023 American International Group Inc.29,698$332K0.0%N/A0.013% 8/3/2023 Bank of New York Mellon Corp163,811$1.83M0.0%N/A0.070% 7/31/2023 Strs Ohio12,800$143K0.0%N/A0.005% 7/19/2023 Salem Investment Counselors Inc.3,000$34K0.0%+547.9%0.001% 2/13/2023 Social Capital Group LLC13,273,000$91.05M77.7%N/A51.767% 2/8/2023 Swiss National Bank74,301$510K0.0%N/A0.290% 1/24/2023 Brown University1,000,000$6.86M2.9%N/A3.900% 11/15/2022 Bleichroeder LP2,000,000$18.02M3.8%N/A7.800% 11/14/2022 Verition Fund Management LLC14,603$132K0.0%N/A0.057% 11/14/2022 Moore Capital Management LP26,500$239K0.0%N/A0.103% (Data available from 1/1/2016 forward) PROK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PROK shares? During the previous two years, 40 institutional investors and hedge funds held shares of ProKidney. The most heavily invested institutionals were Social Capital Group LLC ($53.00M), Suvretta Capital Management LLC ($23.70M), Bleichroeder LP ($3.38M), Vanguard Group Inc. ($2.97M), State Street Corp ($2.74M), Northern Trust Corp ($1.51M), and JPMorgan Chase & Co. ($988K).Learn more on ProKidney's institutional investors. What percentage of ProKidney's stock is owned by institutional investors? 51.59% of ProKidney's stock is owned by institutional investors. Learn more on PROK's institutional investor holdings. Which institutional investors have been buying ProKidney's stock? Of the 35 institutional investors that purchased ProKidney's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Suvretta Capital Management LLC ($3M), JPMorgan Chase & Co. ($1.65M), Geode Capital Management LLC ($1.14M), Hennion & Walsh Asset Management Inc. ($844.28K), Jane Street Group LLC ($591.69K), Charles Schwab Investment Management Inc. ($526.48K), and Marshall Wace LLP ($515.05K). How much institutional buying is happening at ProKidney? Institutional investors have bought a total of 10,212,995 shares in the last 24 months. This purchase volume represents approximately $14.41M in transactions. Which of ProKidney's major shareholders have been selling company stock? The following institutional investors have sold ProKidney stock in the last 24 months: Geode Capital Management LLC ($1.31M), Goldman Sachs Group Inc. ($148.05K), Mariner LLC ($15.94K), Rhumbline Advisers ($9.89K), and Jane Street Group LLC ($6.95K). How much institutional selling is happening at ProKidney? Institutional investors have sold a total of 1,490,977 shares in the last 24 months. This volume of shares sold represents approximately $962.45K in transactions. Related Companies RARE Major Shareholders CRNX Major Shareholders MOR Major Shareholders NAMS Major Shareholders BHC Major Shareholders IMVT Major Shareholders HCM Major Shareholders KNSA Major Shareholders CPRX Major Shareholders TARS Major Shareholders This page (NASDAQ:PROK) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProKidney With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.